Bill Snyder

February 27, 2020

Breast cancer study may help predict treatment response

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.

By Bill Snyder
(iStock)
February 26, 2020

Potential new heartburn drug studied at VUMC

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.

By Bill Snyder
February 20, 2020

Protein interactions and brain function

Roger Colbran and colleagues have discovered new molecular details about the function of an enzyme with a key role in shaping learning and memory.

By Bill Snyder
February 20, 2020

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.

By Bill Snyder
February 19, 2020

Awards honor research staff’s crucial contributions

Laboratory and administrative personnel at VUMC were honored last week for research excellence during the 16th annual Research Staff Awards luncheon.

By Bill Snyder
February 19, 2020

Vanderbilt University Medical Center among top 100 proposals for MacArthur Foundation $100 million grant

The John D. and Catherine T. MacArthur Foundation today unveiled a grant proposal from Vanderbilt University Medical Center (VUMC) as one of the highest-scoring proposals, designated as the “Top 100,” in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical societal challenges.

By Bill Snyder
February 13, 2020

Algorithm helps improve coronary calcium detection

A new algorithm for artificial intelligence-assisted calcium scoring can accurately determine cardiovascular risk across a range of CT scans and in a racially diverse population.
By Bill Snyder
February 6, 2020

Antibody mixture may help block Ebola virus infection

A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is highly effective in blocking infection by the Ebola virus.
By Bill Snyder
February 6, 2020

Conn, Calipari to receive major pharmacology awards

Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
February 6, 2020

Carnahan named associate director of Vaccine Center

Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center.
By Bill Snyder
February 6, 2020

Genetics and EHRs

Lisa Bastarache, MS, research assistant professor of Biomedical Informatics, and Tony Capra, PhD, associate professor of Biological Sciences and Biomedical Informatics, described the intersection of genetics and electronic health records during last week’s Cutting-Edge Discovery Lecture.
By Bill Snyder
February 6, 2020

Team tracks integrin’s role in lung function

Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.
By Bill Snyder